Driving the Future of Innovation in Cell & Gene Therapy, Together

Plenary Session

8:30 a.m. - 12:15p.m.

Chair: Priyanka Gupta & Maya Fuerstenau-Sharp

We’re kicking off the 2025 CGT Forum with an engaging and interactive plenary session featuring leaders from across the cell and gene therapy landscape. Join us for timely market insights, a lively panel discussion on the evolving regulatory environment, and a closer look at how investment trends—especially for CGT start-ups—are shaping the future. The session will also explore how data analytics and AI are being used to accelerate ATMP development. Come ready to ask questions, share perspectives, and connect with others driving innovation in this fast-moving field.

​

Gene Therapy | NA Track

1:15 p.m. - 5:15 p.m.

Chair: Paul Cashen ​

Join leading voices as they share the newest developments in AAV, mRNA, and plasmid DNA, highlighting separate pathways and novel solutions shaping the future of gene therapy. Get an inside look into developing a scalable AAV platform, using data analytics to improve performance, tackling production challenges and enabling process optimization. Explore how real-time PAT and computational controls are driving smarter, more efficient manufacturing. Learn from academic case studies that reveal new directions in both AAV and mRNA research. Discover how modular cleanroom designs are enabling scalable, flexible plasmid DNA manufacturing and see how analytics and model-driven approaches are optimizing viral vector production. Bringing together strategies for optimization and platform innovation, this track presents fresh insights into AAV and nucleic acid development.

Cell Therapy Track

1:15 p.m. - 5:15 p.m.

Chair: Shanya Jiang​

Dive into the cutting edge of cell therapy innovation with a dynamic series of presentations designed to inspire and inform. Gain insights from the hospital’s perspective on designing truly personalized therapies and explore breakthroughs in iPSC-based 3D bioprinting that are redefining regenerative medicine. Discover how non-viral gene editing using lipid-based transfection is enabling safer, more efficient cell engineering, and learn about the latest advances in stem cell scale-up using stirred tank bioreactors. Whether you're focused on clinical translation or manufacturing optimization, this track offers a front-row seat to the future of cell therapies.